Balkan Journal of Medical Genetics

VARIANTS IN MITOCHONDRIAL tRNA GENE MAY NOT BE ASSOCIATED WITH THYROID CARCINOMA
Lv F1,a, Qian G2,a, You W1,a, Lin H3, Wang XF3, Qiu GS2, Jiang YS2, Pang LX3, Kang YM4, Jia BF4, Xu JZ5,*, Yu Y1,*
*Corresponding Author: Dr. Jinzhong Xu, Department of Clinical Pharmacy, the Affiliated Wenling Hospital of Wenzhou Medial University, Taiping Nan Road 190, Wenling 317500, People’s Republic of China. Tel./Fax: +86-(0)576-8620-6288. E-mail: xujzwl@163.com and Dr. Yang Yu, Department of Breast Surgery, Henan Provincial People’s Hospital, Weiwu Road 7, Zhengzhou 450003, People’s Republic of China. Tel./Fax: +86-(0)371- 6558-0014. E-mail: 510790135@qq.com
page: 59

RESULTS

Study Characteristics. As a result, three studies were identified using the keywords mentioned in the previous section. After a full-text review, we noticed that one of them concerned the somatic mtDNA mutations in PTC [12]. Another article that met our inclusion criteria was about the association of mtDNA transversion mutations with familiar MTC [13], whereas another article talked mainly about the mtDNA mutations causing defective OXPHOS in thyroid carcinoma [14]. Selecting Thyroid Carcinoma Associated mttRNA Variants. We further screened the mt-tRNA variants that had been reported with thyroid cancer. Consequently, a total of seven mt-tRNA variants were described: tRNAAsp G7521A, tRNAArg T10411C and T10463C, tRNALeu(CUN) A12308G, tRNAIle G4292C and C4312T, and tRNAAla T5655C. The molecular characterization of these mt-tRNA variants are listed in Table 1 and Figure 1. Conservation Assessment of These Variants. Assessing pathogenicity of a nt substitution in a mttRNA gene involved evaluation of the evolutionary conservation of the base involved. For this purpose, we analyzed the CIs of these mt-tRNA variants. Briefly, we chose 15 animals for inter-species analysis, these species included Mus musculus, Gorilla gorilla, Hylobates lar, Lemur catta, Pan paniscus, Homo sapiens, Thylamys elegans, Procavia capensis, Cavia porcellus, Orycteropus afer, Bos taurus, Sus scrofa, Felis catus, Platanista minor and Herpestes javanicus. We used the sequences derived from mammalian mitochondrial tRNA genes (http://mamit-trna.u strasbg.fr/) [15]. The CI was calculated by comparing the corresponding nt at the position of mt-tRNA. We found that the T10463C, A12308G and T5655C variants exhibited the highest level of CI, whereas other mutations lacked high level of CIs. Notably, the CI of the A12308G mutation is 93.3% (Figure 2). Prediction of the ⊿G of Each mt-tRNA. We used the RNA Fold Web Server (http://rna.tbi.univie. ac.at/cgi-bin/ RNAfold. cgi) to calculate the ⊿G of each mt-tRNA with and without these mutations, as listed in Table 1. Surprisingly, none of these variants caused significant alternation of ⊿G between the wildtype and the mutant mt-tRNAs, it seemed that they may not play important roles in thyroid carcinoma. Mutational Analysis of the tRNALeu(CUN) Gene. By comparing the human mitochondrial genome sequence, we found that there were five thyroid cancer patients and three control subjects carrying the homoplasmic A12308G variant, suggesting that it may be very polymorphic in the human population.

Number 27 VOL. 27 (2), 2024	Number 27 VOL. 27 (1), 2024
Number 26 Number 26 VOL. 26(2), 2023 All in one	Number 26 VOL. 26(2), 2023
Number 26 VOL. 26, 2023 Supplement	Number 26 VOL. 26(1), 2023
Number 25 VOL. 25(2), 2022	Number 25 VOL. 25 (1), 2022
Number 24 VOL. 24(2), 2021	Number 24 VOL. 24(1), 2021
Number 23 VOL. 23(2), 2020	Number 22 VOL. 22(2), 2019
Number 22 VOL. 22(1), 2019	Number 22 VOL. 22, 2019 Supplement
Number 21 VOL. 21(2), 2018	Number 21 VOL. 21 (1), 2018
Number 21 VOL. 21, 2018 Supplement	Number 20 VOL. 20 (2), 2017
Number 20 VOL. 20 (1), 2017	Number 19 VOL. 19 (2), 2016
Number 19 VOL. 19 (1), 2016	Number 18 VOL. 18 (2), 2015
Number 18 VOL. 18 (1), 2015	Number 17 VOL. 17 (2), 2014
Number 17 VOL. 17 (1), 2014	Number 16 VOL. 16 (2), 2013
Number 16 VOL. 16 (1), 2013	Number 15 VOL. 15 (2), 2012
Number 15 VOL. 15, 2012 Supplement	Number 15 Vol. 15 (1), 2012
Number 14 14 - Vol. 14 (2), 2011	Number 14 The 9th Balkan Congress of Medical Genetics
Number 14 14 - Vol. 14 (1), 2011	Number 13 Vol. 13 (2), 2010
Number 13 Vol.13 (1), 2010	Number 12 Vol.12 (2), 2009
Number 12 Vol.12 (1), 2009	Number 11 Vol.11 (2),2008
Number 11 Vol.11 (1),2008	Number 10 Vol.10 (2), 2007
Number 10 10 (1),2007	Number 9 1&2, 2006
Number 9 3&4, 2006	Number 8 1&2, 2005
Number 8 3&4, 2004	Number 7 1&2, 2004
Number 6 3&4, 2003	Number 6 1&2, 2003
Number 5 3&4, 2002	Number 5 1&2, 2002
Number 4 Vol.3 (4), 2000	Number 4 Vol.2 (4), 1999
Number 4 Vol.1 (4), 1998	Number 4 3&4, 2001
Number 4 1&2, 2001	Number 3 Vol.3 (3), 2000
Number 3 Vol.2 (3), 1999	Number 3 Vol.1 (3), 1998
Number 2 Vol.3(2), 2000	Number 2 Vol.1 (2), 1998
Number 2 Vol.2 (2), 1999	Number 1 Vol.3 (1), 2000
Number 1 Vol.2 (1), 1999	Number 1 Vol.1 (1), 1998

About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact